Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Mar 26, 2021 9:30am
132 Views
Post# 32885147

RE:RE:RE:RE:RE:RE:RE:Cash Value ...

RE:RE:RE:RE:RE:RE:RE:Cash Value ...
schocor wrote:

 

Chianchin wrote: Since you all are so smart, about doing a reverse calcualtion for how GBT lost in the last quarter?  Gud Did not provide "interesting" that but I am curious if you know it. It is very simple to do it. Do the math and tell it to this forum 

 

 

sigh cjisnchin.  Were the losses from gbt this quarter OPERATIONS losses or FINANCIAL/INVEST!ENT losses? Exactly. You can only write a cash flow positive business down so far. SO gbt has value. swing and a miss. 

the integration of the latin america assets seems to have taken a step forward this quarter. There wasnt much discussed in the uses for that credit line. They did say there were agressivly buying back shares at 5.25 in the last 3 months. There are a few new theraputics released as well.

It would be nice to see this trade in the 5.25-5.75 range for the next quarter, but this is a long term hold for me. 

 


 




Exactly ... this has to be viewed as a long term play.

They have work to do with the century home they purchased but it's in a prime location and it's spacious.  It just needs some work ... some TLC.

In other news ...

A little birdy tells me Benny has finally given up - sold all his GUD shares.  GUD for him as he just doesn't understand this investment.  He's now touting the glory of ATE - haven't the heart to remind him that ATE started back in 2009 and that has been a long and bumpy 12 years.  You also have to add the years they were chasing NO as a gaseous mediator - before realizing H2S would be their future.

Moral of the story - growth companies need time to establish their base and grow from it.  You can't put the roof on first to stay dry ... and decide to add a foundation later.  There's no success in that.  IMO.

Cheers !
<< Previous
Bullboard Posts
Next >>